Myoclonus from selective dentate nucleus degeneration in type 3 Gaucher disease

Archives of Neurology

Volumn 57, Issue 3, 2000, Pages 389-395

  Verghese, Joe ^a   Goldberg, Rina F ^a   Desnick, Robert J ^b   Grace, Marie E ^b   Goldman, James E ^a,c   Lee, Sunhee C ^a   Dickson, Dennis W ^a,d   Rapin, Isabelle ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c Columbia Univ Coll Phys Surgs ^*  (United States)

^d MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CASE REPORT; DENTATE NUCLEUS; FEMALE; GAUCHER DISEASE; GENETIC VARIABILITY; HUMAN; MYOCLONUS; NERVE DEGENERATION; PATHOGENESIS; PRESCHOOL CHILD; PRIORITY JOURNAL;

EID: 0034011426     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.57.3.389     Document Type: Article

References (53)

1. Beutler E, Grabowski GA. Gaucher disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic Basis of Inherited Disease. New York, NY: McGraw-Hill Co; 1994;2641-2670.
2. Desnick RJ, Gatt S, Grabowski GA. Gaucher Disease: A Century of Delineation and Research. New York, NY: Alan R Liss Inc; 1982.
3. Erikson A, Bembi B, Schiffman R, Neuronopathic forms of Gaucher disease. Clin Haematol. 1997;10:711-723.
4. Brady RO, Barton NW, Grabowski GA. The role of neurogenetics in Gaucher disease. Arch Neurol. 1993;50:1212-1224.
5. Tripp JH, Lake BD, Young E, Ngu J, Brett EM. Juvenile Gaucher's disease with horizontal gaze palsy in three siblings. J Neurol Neurosurg Psychiatry. 1977;40:470-478.
6. Beutler E. Gaucher disease. Adv Genet. 1995;32:17-49.
7. Miyatake T, Suzuki K. Globoid cell leukodystrophy: additional deficiency of psychosine galactosidase. Biochem Biophys Res Commun. 1972;48:538-543.
8. Suzuki K. Twenty-five years of the "psychosine hypothesis": a personal perspective of its history and present status. Neurochem Res. 1998;23:251-259.
9. Nilsson O, Svennerholm L. Accumulalion of glucosylcerarnide and glucosylsphingosine (psychosine) in cerebrum and cerebellum in infantile and juvenile Gaucher disease. J Neurochem. 1982;39:709-718.
10. Nilsson O, Grabowski GA, Ludman MD, Desnick RJ, Svennerholm L. Glycosphingolipid studies of visceral tissues and brain from type 1 Gaucher disease. Clin Genet. 1985;27:443-450.
11. Strasberg P. Cerebrosides and psychosine disrupt mitochondrial functions. Biochem Cell Biol. 1986;64:485-489.
12. Tapasi S, Padma P, Setty OH. Effect of psychosine on mitochondrial function. Indian J Biochem Biophys. 1998;35:161-165.
13. Sidransky E, Ginns EI. Gaucher's disease: the best laid schemes of mice and men. Baillieres Clin Haematol. 1997;10:725-737.
14. Bembi B, Zanatta M, Carrozzi M, et al. Enzyme replacement treatment in type 1 and type 3 Gaucher's disease. Lancet. 1994;344:1679-1682.
15. Schiffmann R, Heyes MP, Aerts JM, et al. Prospective study of neurological responses to treatment with macrophage-targeted glucocerebrosidase in patients with type 3 Gaucher disease. Ann Neurol. 1997;42:613-621.
16. Hallett M, Chadwick D, Adam J, et al. Reticular reflex myoclonus: a physiological type of human post-hypoxic myoclonus. J Neurol Neurosurg Psychiatry. 1977;40:253-264.
17. Hallett M, Chadwick D, Marsden CD. Cortical reflex myoclonus. Neurology. 1979;29:1107-1125.
18. Halliday AM. Evolving ideas on the neurophysiology of myoclonus. In: Fahn S, Marsden CD, Van Woert MH, eds. Myoclonus: Advances in Neurology. Vol 43. New York, NY: Raven Press; 1986:339-355.
19. Brown P, Thompson PD, Rothwell JC, Day BL, Marsden CD. A case of postanoxic encephalopathy with cortical action and brainstem reticular reflex myoclonus. Mov Disord. 1991;6:139-144.
20. Lance JW. Action myoclonus, Ramsay Hunt Syndrome, and other cerebellar myoclonic syndromes. In: Fahn S, Marsden CD, Van Woert MH, eds. Myoclonus: Advances in Neurology. Vol 43. New York, NY: Raven Press; 1986:33-55
21. Lance JW, Adams RD. The syndrome of intention or action myoclonus as a sequel to hypoxic encephalopathy. Brain. 1963;86:111-136.
22. Chadwick D, French AT. Uraemic myoclonus: an example of relicular reflex myoclonus? J Neurol Neurosurg Psychiatry. 1979;42:52-55.
23. Berkovic SF, Andermann F, Capenter S, Wolfe LS. Progressive myoclonus epilepsies: specific causes and diagnosis. N Engl J Med. 1986;315:296-305.
24. Sibille A, Eng C, Kim S-J, Pastores G, Grabowski GA. Phenotype/genotype correlations in Gaucher disease type 1: clinical and therapeutic implications. Am J Hum Genet. 1993;52:1094-1101.
25. Beutler E, Gelbart T, West C. The facile detection of the nt 1226 mutation ot glucocerebrosidase by "mismatched" PCR. Clin Chim Acta. 1990;194:161-166.
26. Tsuji S, Choudary P, Martin B, et al. A mutation in the human glucocerebrosidase gene in neuronopathic Gaucher's disease. N Engl J Med. 1987;316:570-575.
27. Beutler E, Gelbart T, Kuhl W, Sorge J, West C. Identification of the second common Jewish Gaucher disease mutation makes possible population-based screening for the heterozygous state. Proc Natl Acad Sci U S A. 1991;88:10544-10547.
28. +1 IVS2 splice donor site mutation causing exon 2 skipping in the acid β-glucosidase mRNA. Am J Hum Genet. 1992;51:810-820.
29. Grabowski GA, Horowitz M. Gaucher's disease: molecular, genetic and enzymological aspects. Clin Haematol. 1997;10:635-656.
30. Latham T, Grabowski GA, Theophilus BDM, Smith F. Complex alleles of the acid β-glucosidase gene in Gaucher disease. Am J Hum Genet. 1990;47:79-86.
31. Horowitz M, Wilder S, Horowitz Z, Reiner O, Gelbart T, Beutler E. The human glucocerebrosidase gene and pseudogene: structure and evolution. Genomics. 1989;4:87-96.
32. Grace ME, Newman KM, Scheinker V, Berg-Fussman A, Grabowski GA. Analysis of human acid β-glucosidase by site-directed mutagenesis and heterologous expression. J Biol Chem. 1994;269:2283-2291.
33. Rekate HL, Grubb RL, Aram DM, Hahn JF, Ratcheson RA. Muteness of cerebellar origin. Arch Neural. 1985;42:697-698.
34. Cogan DG. A type of congenital ocular motor apraxia presenting jerky head movements. Trans Am Acad Ophthalmol Otolaryngol. 1952;56:853-862.
35. Cogan DG. Congenital oculomotor apraxia. Can J Ophthalmol. 1966;1:253-260.
36. Moschner C, Perlman S, Baloh RW. Comparison of oculomotor findings in the progressive ataxia syndromes. Brain. 1994;117:15-25.
37. Eccles JC, Ito M, Szentagothai J. The Cerebellum as a Neuronal Machine. New York, NY: Springer-Verlag; 1967:227-299.
38. Afifi AK, Bergman RA. Cerebellum. In: Afifi AK, Bergman RA, eds. Functional Neuroanatomy. New York, NY: McGraw-Hill Inc; 1998:306-329.
39. Winkelman MD, Banker BQ, Victor M, Moser HW. Non-infantile neuronopathic Gaucher's disease: a clinicopathological study. Neurology. 1983;33:994-1008.
40. Conradi N, Kyllerman M, Mansson JE, Percy AK, Svennerholm L. Late-infantile Gaucher disease in a child with myoclonus and bulbar signs: neuropathological and neurochemical findings, Acta Neuropathol (Berl). 1991;82:152-157.
41. Moss TH, Stevens DL, Campbell MJ. Progressive myoclonus epilepsy with focal brain stem degeneration and paternal inheritance: an autopsy report of 4 cases from 2 pedigrees. Clin Neuropathol. 1996;15:106-112.
42. Ziter FM, Bray PF, Cancilla PA. Neuropathologic findings in a patient with neuroblastoma and myoclonic encephalopathy. Arch Neurol. 1979;36:51.
43. Oka H, Matsushima M. Ando K, Hoshizaki H. Intention myoclonus in acute leukemia. Brain. 1972;95:395-398.
44. Fitzsimons RB, Clifton-Bligh P, Wolfenden WH. Mitochondrial myopathy and lactic acidemia with myoclonic epilepsy, ataxia and hypothalamic infertility: a variant of Ramsay-Hunt syndrome? J Neurol Neurosurg Psychiatry. 1981;44:79-82.
45. Rapin I, Goldfischer S, Katzman R, Engel J Jr, O'Brien JS. The cherry-red spot-myoclonus syndrome, Ann Neurol. 1978;3:234-242.
46. Unverricht H. Die Myoclonie. Leipzig, Germany: Franz Deuticke; 1891:1-128.
47. Koskiniemi M, Donner M, Majuri H, Halita M, Norio R. Progressive myoclonus epilepsy: a clinical and histopathological study. Acta Neurol Scand. 1974;50:307-332.
48. Lafora GR, Glueck B. Beitrag zur histopathologie der myoklonischen Epilepsie. Z Gesamte Neurol Psychiatr. 1911;6:1-14.
49. Rapin I. Myoclonus in neuronal storage and Lafora disease. In: Fahn S, Marsden CD, Van Woert MH, eds. Myoclonus: Advances in Neurology. Vol 43. New York, NY: Raven Press; 1986:65-85.
50. Chung E, Van Woert MH. DDT myoclonus: site of a myoclonus center in the brain. In: Fahn S, Marsden CD, Van Woert WH, eds. Myoclonus: Advances in Neurology. Vol 43. New York, NY: Raven Press; 1986:569-575.
51. Eriksson A. Gaucher disease-Norrbottnian type (III): neuropediatric and neurobiological aspects of clinical patterns and treatment. Acta Paediatr Scand. 1986;326(suppl):1-41.
52. Dreborg S, Eriksson A, Hagberg B. Gaucher disease-Norrbottnian type I: general clinical description. Eur J Pediatr. 1980;133:107-118.
53. Kaye EM, Ullman MD, Wilson ER, Sarranger JA. Type 2 and type 3 Gaucher disease: a morphological and biochemical study. Ann Neurol. 1986;2:223-230.